Skip to search.
 TSX Up 0.47% TSX Ventures Up 1.46%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
5.84 Down 0.32(5.19%) 4:00PM EDT
|After Hours : 5.84 0.00 (0.00%) 4:35PM EDT
Prev Close:6.16
Open:6.16
Bid:5.60 x 200
Ask:6.03 x 500
1y Target Est:24.83
Beta:1.55202
Next Earnings Date: 2-May-16RGLS Earnings announcement
Day's Range:5.77 - 6.32
52wk Range:5.14 - 14.50
Volume:628,034
Avg Vol (3m):926,675
Market Cap:308.24M
P/E (ttm):N/A
EPS (ttm):-1.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.39
Quarterly EPS Est (Mar-16) :-0.33
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback